Noting that 60 per cent to 70 per cent of the children who got infected and got admitted in hospitals during the second wave in India, had either comorbidities or low immunity, the All India Institute of Medical Sciences (AIIMS) Director said that healthy children recovered with mild illness without need for hospitalisation.
The maximum price of Covishield for private COVID-19 Vaccination Centres (CVCs) has been fixed at Rs 780 per dose, while that of Covaxin is Rs 1,410 per dose and Sputnik V Rs 1,145 per dose, it said.
The series of lockdowns and shutdowns enforced by the State government of Odisha has really fructified results as anticipated, DMET CBK Mohanty said today.
A latest study has found that both vaccines, Covishield and Covaxin elicited a good immune response after two doses, although seropositivity rates and the median anti-spike antibody titre was significantly higher in Covishield as compared to Covaxin.
Vaccine manufacturer, Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking permission to manufacture Russian COVID vaccine Sputnik V in India. As per sources, the Pune-based vaccine maker has also sought permission for test analysis and examination.
The Odisha Health and Family Welfare Department on Wednesday issued advisory for the physicians and beneficiaries to report suspected Thrombosis after Covishield vaccine administration.
The Union government has reiterated to the states/UTs that online appointments booked for second dose of Covishield prior to this change of the interval between the two doses of Covishield, must be honoured.
Gap between two doses of Covishield vaccine increased. A day after the Union Health ministry increased the gap between 2 doses of Covishield, Odisha announced the changes. Union Health Ministry widened the gap between 2 doses of Covishield from 42 days (6 weeks) to 84 days
The Ministry of Health and Family Welfare (MoHFW) had on Thursday widened the gap between two doses of Serum Institute of India’s Covidshield vaccine from 42 days (6 weeks) to 84 days (12weeks).
The Centre on Thursday approved extending the gap between the two doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks.
A government panel has recommended increasing the gap between two doses of Covishield COVID-19 vaccine to 12-16 weeks and said that pregnant women may be offered the choice to take any vaccine
The Centre has told the Supreme Court that no governmental aid, assistance or grant was made either for research or development of either Covaxin or Covishield vaccines but some financial assistance was given for conducting clinical trials.
Bhubaneswar: Amid a shortage of vaccines in Odisha, the State government on Monday put persons eligible for 2nd dose of Covishield vaccine on a priority list. A notification in this…
Bhubaneswar: To ensure second dose of vaccine to people aged 45 years and above, the Odisha government on Friday asked the Centre to urgently supply at least 25 lakh doses…
London: A single dose of a Pfizer or AstraZeneca vaccine against coronavirus disease can reduce transmission by up to 50 per cent, finds a study. The study led by UK’s…
Copyright © 2024 - Odisha Television Limited All Rights Reserved.